VOURAGE
Live / Registered — Registered (as of 06 May 2025)
What this means for you
Registered since 06 May 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 06 May 2031: the §8 declaration of use).
Record
- Serial number
- 98712439
- Registration number
- 7787081
- Mark type
- Word mark
- Filed
- 22 Aug 2024
- Published for opposition
- 18 Mar 2025
- Registered
- 06 May 2025
- Next maintenance filing
- §8 declaration of use, due by 06 May 2031 (grace period to 06 Nov 2031)
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
Owner
- GLAXO GROUP LIMITED, Stevenage, GB
- GLAXO GROUP LIMITED, Stevenage, GB
- GLAXO GROUP LIMITED, Stevenage, GB
Prosecution history
- 06 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 18 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Mar 2025 — PUBLISHED FOR OPPOSITION
- 12 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION
- 22 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jan 2025 — ASSIGNED TO EXAMINER
- 22 Aug 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Aug 2024 — NEW APPLICATION ENTERED